InnoCare Pharma Limited (HKG:9969)

Hong Kong · Delayed Price · Currency is HKD

11.83

+0.61 (5.44%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Pharmaceuticals	1.01B	738.54M	625.40M	1.04B	1.36M
Pharmaceuticals Growth	36.68%	18.09%	-40.04%	76368.70%	9.38%
Total	1.01B	738.54M	625.40M	1.04B	1.36M
Total Growth	36.68%	18.09%	-40.04%	76368.70%	9.38%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Mainland China	1.01B	673.13M	568.04M	216.07M	1.36M
Mainland China Growth	49.33%	18.50%	162.90%	15740.62%	9.38%
Other countries/regions	4.24M	65.40M	57.37M	826.97M	-
Other countries/regions Growth	-93.52%	14.00%	-93.06%	-	-
Total	1.01B	738.54M	625.40M	1.04B	1.36M
Total Growth	36.68%	18.09%	-40.04%	76368.70%	9.38%

Source: S&P Global Market Intelligence.